These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23100616)

  • 41. The Advantages of Adding Hyaluronic Acid or Mannitol to Hypertonic Saline Inhalation Treatment in Cystic Fibrosis.
    Cazzarolli C; Tartali C; Pradal U
    J Aerosol Med Pulm Drug Deliv; 2017 Apr; 30(2):141-142. PubMed ID: 27563742
    [No Abstract]   [Full Text] [Related]  

  • 42. Cystic fibrosis: comparison of two mucolytic drugs for inhalation treatment (acetylcysteine and arginine hydrochloride).
    Dietzsch HJ; Gottschalk B; Heyne K; Leupoid W; Wunderlich P
    Pediatrics; 1975 Jan; 55(1):96-100. PubMed ID: 1110869
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: three areas for future research Which areas to target? Which particle size to deliver? Which device to use?
    Rottier BL; de Boer AH; Duiverman EJ
    J Cyst Fibros; 2010 Jul; 9(4):296-7. PubMed ID: 20435528
    [No Abstract]   [Full Text] [Related]  

  • 44. Update in cystic fibrosis 2008.
    Ratjen F
    Am J Respir Crit Care Med; 2009 Mar; 179(6):445-8. PubMed ID: 19264980
    [No Abstract]   [Full Text] [Related]  

  • 45. [Changes in the respiratory function in cystic fibrosis].
    Battistini A; Grzincich GL; Benaglia G
    Minerva Pediatr; 1976 Jan; 28(2):73-80. PubMed ID: 1256389
    [No Abstract]   [Full Text] [Related]  

  • 46. Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosis.
    Ren CL; Pasta DJ; Rasouliyan L; Wagener JS; Konstan MW; Morgan WJ;
    J Pediatr; 2008 Dec; 153(6):746-51. PubMed ID: 18760805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vitamin A and lung function in CF.
    Aird FK; Greene SA; Ogston SA; Macdonald TM; Mukhopadhyay S
    J Cyst Fibros; 2006 May; 5(2):129-31. PubMed ID: 16650745
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The treatment of cystic fibrosis--step by step.
    Hazinski TA
    J Pediatr; 2001 Oct; 139(4):3A. PubMed ID: 11598588
    [No Abstract]   [Full Text] [Related]  

  • 49. Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solution.
    Sawicki GS; Signorovitch JE; Zhang J; Latremouille-Viau D; von Wartburg M; Wu EQ; Shi L
    Pediatr Pulmonol; 2012 Jan; 47(1):44-52. PubMed ID: 21815282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lung function testing in the assessment of lung involvement in cystic fibrosis.
    Zapletal A
    Acta Univ Carol Med (Praha); 1990; 36(1-4):183-94. PubMed ID: 2130691
    [No Abstract]   [Full Text] [Related]  

  • 51. Mannitol as a mucolytic in cystic fibrosis.
    Minasian CC; Wallis C; Bush A
    J R Soc Med; 2007; 100 Suppl 47():53-6. PubMed ID: 17926730
    [No Abstract]   [Full Text] [Related]  

  • 52. Placebo-controlled n-of-1 trials in cystic fibrosis.
    Webb S; Tansey P; Brown H; Jackson A; Bilton D
    Eur Respir J; 1999 Oct; 14(4):993; author reply 994. PubMed ID: 10573255
    [No Abstract]   [Full Text] [Related]  

  • 53. Use of bronchodilator therapy in cystic fibrosis.
    Chernick V
    Pediatr Pulmonol Suppl; 1997; 16():275. PubMed ID: 9443310
    [No Abstract]   [Full Text] [Related]  

  • 54. The effect of 12 months' treatment with eicosapentaenoic acid in five children with cystic fibrosis.
    Thies NH
    J Paediatr Child Health; 1997 Aug; 33(4):349-51. PubMed ID: 9323627
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nonantibiotic inhaled therapy in cystic fibrosis: new data.
    Lindemann H
    Pediatr Pulmonol Suppl; 1995; 11():70-1. PubMed ID: 7547355
    [No Abstract]   [Full Text] [Related]  

  • 56. A double-edged sword.
    Prescrire Int; 2014 Apr; 23(148):91. PubMed ID: 24860890
    [No Abstract]   [Full Text] [Related]  

  • 57. Glutathione: a radical treatment for cystic fibrosis lung disease?
    Day BJ
    Chest; 2005 Jan; 127(1):12-4. PubMed ID: 15653956
    [No Abstract]   [Full Text] [Related]  

  • 58. The cystic fibrosis drug market.
    Syed BA; Hamad B
    Nat Rev Drug Discov; 2014 Oct; 13(10):721-2. PubMed ID: 25270952
    [No Abstract]   [Full Text] [Related]  

  • 59. Summary of drug needs in cystic fibrosis.
    Boucher RC; Beall RJ
    Pharm Res; 1989 Jun; 6(6):525-7. PubMed ID: 2668916
    [No Abstract]   [Full Text] [Related]  

  • 60. [Many patients with cystic fibrosis have a better quality of life now].
    Eschenhagen P; Schwarz C
    MMW Fortschr Med; 2021 Mar; 163(Suppl 1):74-81. PubMed ID: 33950452
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.